Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case report

Valentina Tuninetti, Roberta Danese, Amedeo Calvo, Marco Bellero, Lavinia Bianco, Valentina Ariu, Maria Grazia Ruo Redda, Paola Campisi, Alessandra Bianco, Giovanni De Rosa, Massimo Petracchini, Giorgio Valabrega

Article Type

Case Report

Published

This article describes the case of a woman with deficient mismatch repair/microsatellite instability endometrial cancer who did not respond to first-line treatment with carboplatin and paclitaxel but had a high response to subsequent immunotherapy with dostarlimab.

Read more

Obinutuzumab in membranous nephropathy: a potential game-changer in treatment

Concetto Sessa, Dario Galeano, Luca Zanoli, Marco Delsante, Giovanni Maria Rossi, Walter Morale

Article Type

Review

Published

This articles reviews the pathophysiology of membranous nephropathy (MN), the mechanism of action of obinutuzumab, clinical data supporting its use and discusses its potential as a game changer in MN treatment.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.